Steris PLC Form 4 insider transactions

Cary L. Majors, SVP and President, Healthcare at STERIS plc, exercised stock options and sold shares on May 20, 2025.

Cary L. Majors, SVP and President of Healthcare at STERIS plc, sold 1,682 ordinary shares at an average price of $217.32 per share on November 25, 2024.

John Adam Zangerle, a Senior VP at STERIS plc, disposed of 91 ordinary shares to cover tax obligations related to vested restricted shares.

Michael Tokich, Sr. Vice President and CFO of STERIS plc, reports the withholding of shares to cover tax obligations upon vesting of restricted shares.

Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, reports the withholding of 78 shares for tax obligations related to vested restricted shares on October 1, 2024.

Julia Madsen, Sr. VP and GM of Life Sciences at STERIS plc, reports the withholding of 250 ordinary shares to cover tax obligations upon vesting of restricted shares on October 1, 2024.

Daniel Carestio, President and CEO of STERIS plc, reports the withholding of 130 ordinary shares to cover tax obligations upon vesting of restricted shares.

Karen L. Burton, VP & CAO of STERIS plc, reports the withholding of 26 ordinary shares to cover tax obligations related to vesting restricted shares on October 1, 2024.

Director Mohsen Sohi files an amended SEC Form 4 to correct the previously reported amount of Career Restricted Stock Units acquired on August 8, 2024.

STERIS plc's CFO, Michael Tokich, executed stock options and sold shares in multiple transactions on September 13 and 16, 2024, according to a Form 4 filing with the SEC.

STERIS plc CFO Michael Tokich exercised stock options and sold 23,332 ordinary shares at an average price of $247, while also acquiring the same number of shares at $114.22.

Director Richard Martin Steeves reports the acquisition of stock options and restricted stock units in STERIS plc, including grants in lieu of fees.

Director Mohsen Sohi reports the acquisition of stock options and restricted stock units in STERIS plc.

Director Nirav R. Shah of STERIS plc reports acquisition of stock options and restricted stock units, fully vested immediately.

Director Paul Edward Martin acquired stock options and restricted stock units in STERIS plc on August 8, 2024, according to a Form 4 filing.

Director Jacqueline B. Kosecoff acquired stock options and restricted stock units in STERIS plc on August 8, 2024, according to a Form 4 filing with the SEC.

Director Christopher Holland reports acquiring and disposing of STERIS plc shares on August 8, 2024, according to a Form 4 filing.

Director Cynthia L. Feldmann reports the acquisition of stock options and restricted stock units in STERIS plc.

Director Richard C. Breeden reports the acquisition of stock options and restricted stock units in STERIS plc, including options granted in lieu of fees.

Director Esther M. Alegria acquired 988 Career Restricted Stock Units in STERIS plc, which will be settled in ordinary shares six months after cessation of board service.

Cary L. Majors, SVP and President, Healthcare at STERIS plc, exercised stock options and sold shares on June 5, 2024.

Julia Madsen, Senior VP of Life Sciences at STERIS plc, reports exercising stock options and selling shares on June 5, 2024.

SVP and President of Healthcare at STERIS plc, Cary L. Majors, reports acquisition of shares and options, indicating changes in beneficial ownership.

John Adam Zangerle, a Senior VP at STERIS plc, acquired shares and options in the company on June 4, 2024.

Kenneth E. Kohler, SVP & GM at STERIS plc, reports the acquisition of shares and stock options.

Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, reports acquisition of ordinary shares and stock options.

Michael Tokich, Sr. Vice President and CFO of STERIS plc, reports the acquisition of shares and stock options, as well as adjustments to holdings in the company's 401(k) plan.

Julia Madsen, Senior VP of Life Sciences at STERIS plc, reports acquisition of shares and stock options.

STERIS plc's CEO, Daniel A. Carestio, reports acquisition of shares and stock options.

Karen L. Burton, VP & CAO of STERIS plc, reports acquisition of shares and stock options.